Genetic testing and bioinformatics company Sema4 said on Wednesday that it is joining with Avera Health to create a data-driven precision medicine program for the healthcare system, Precision Oncology News reports.
The initiative, which will start with oncology, will apply Sema4’s Centrellis cloud-based health intelligence platform to manage, structure, analyze, and integrate genomic and clinical data collected through the Avera Cancer Institute. It builds on a precision oncology program the institute has had for several years that involved sequencing cancer patients’ tumors to guide their treatment. Read more.
